919
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Epigenetic regulation of REG1A and chemosensitivity of cutaneous melanoma

, , , , , & show all
Pages 1043-1052 | Received 08 May 2013, Accepted 18 Jul 2013, Published online: 31 Jul 2013

References

  • Mocellin S, Pasquali S, Rossi CR, Nitti D. Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J Natl Cancer Inst 2010; 102:493 - 501; http://dx.doi.org/10.1093/jnci/djq009; PMID: 20179267
  • Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al, MSLT Group. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355:1307 - 17; http://dx.doi.org/10.1056/NEJMoa060992; PMID: 17005948
  • Kirkwood JM, Moschos S, Wang W. Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations. Clin Cancer Res 2006; 12:2331s - 6s; http://dx.doi.org/10.1158/1078-0432.CCR-05-2538; PMID: 16609054
  • Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010; 363:809 - 19; http://dx.doi.org/10.1056/NEJMoa1002011; PMID: 20818844
  • Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711 - 23; http://dx.doi.org/10.1056/NEJMoa1003466; PMID: 20525992
  • Terazono K, Yamamoto H, Takasawa S, Shiga K, Yonemura Y, Tochino Y, et al. A novel gene activated in regenerating islets. J Biol Chem 1988; 263:2111 - 4; PMID: 2963000
  • Watanabe T, Yonekura H, Terazono K, Yamamoto H, Okamoto H. Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. The reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem 1990; 265:7432 - 9; PMID: 2332435
  • Miyaoka Y, Kadowaki Y, Ishihara S, Ose T, Fukuhara H, Kazumori H, et al. Transgenic overexpression of Reg protein caused gastric cell proliferation and differentiation along parietal cell and chief cell lineages. Oncogene 2004; 23:3572 - 9; http://dx.doi.org/10.1038/sj.onc.1207333; PMID: 15116092
  • Unno M, Itoh T, Watanabe T, Miyashita H, Moriizumi S, Teraoka H, et al. Islet beta-cell regeneration and reg genes. Adv Exp Med Biol 1992; 321:61 - 6, discussion 67-9; http://dx.doi.org/10.1007/978-1-4615-3448-8_8; PMID: 1449083
  • Hayashi K, Motoyama S, Sugiyama T, Izumi J, Anbai A, Nanjo H, et al. REG Ialpha is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients. Ann Surg Oncol 2008; 15:1224 - 31; http://dx.doi.org/10.1245/s10434-008-9810-8; PMID: 18259819
  • Motoyama S, Sugiyama T, Ueno Y, Okamoto H, Takasawa S, Nanjo H, et al. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy. Ann Surg Oncol 2006; 13:1724 - 31; http://dx.doi.org/10.1245/s10434-006-9075-z; PMID: 17009160
  • Sekikawa A, Fukui H, Fujii S, Ichikawa K, Tomita S, Imura J, et al. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Carcinogenesis 2008; 29:76 - 83; http://dx.doi.org/10.1093/carcin/bgm250; PMID: 18024479
  • Yoshino N, Ishihara S, Rumi MA, Ortega-Cava CF, Yuki T, Kazumori H, et al. Interleukin-8 regulates expression of Reg protein in Helicobacter pylori-infected gastric mucosa. Am J Gastroenterol 2005; 100:2157 - 66; http://dx.doi.org/10.1111/j.1572-0241.2005.41915.x; PMID: 16181363
  • Astrosini C, Roeefzaad C, Dai YY, Dieckgraefe BK, Jöns T, Kemmner W. REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis. Int J Cancer 2008; 123:409 - 13; http://dx.doi.org/10.1002/ijc.23466; PMID: 18452172
  • Lee WS, Seo G, Shin HJ, Yun SH, Yun H, Choi N, et al. Identification of differentially expressed genes in microsatellite stable HNPCC and sporadic colon cancer. J Surg Res 2008; 144:29 - 35; http://dx.doi.org/10.1016/j.jss.2007.02.005; PMID: 17950328
  • Kimura N, Yonekura H, Okamoto H, Nagura H. Expression of human regenerating gene mRNA and its product in normal and neoplastic human pancreas. Cancer 1992; 70:1857 - 63; http://dx.doi.org/10.1002/1097-0142(19921001)70:7<1857::AID-CNCR2820700708>3.0.CO;2-8; PMID: 1525759
  • Cavard C, Terris B, Grimber G, Christa L, Audard V, Radenen-Bussiere B, et al. Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations. Oncogene 2006; 25:599 - 608; http://dx.doi.org/10.1038/sj.onc.1208860; PMID: 16314847
  • Minamiya Y, Kawai H, Saito H, Ito M, Hosono Y, Motoyama S, et al. REG1A expression is an independent factor predictive of poor prognosis in patients with non-small cell lung cancer. Lung Cancer 2008; 60:98 - 104; http://dx.doi.org/10.1016/j.lungcan.2007.09.012; PMID: 17964685
  • Sasaki Y, Minamiya Y, Takahashi N, Nakagawa T, Katayose Y, Ito A, et al. REG1A expression is an independent factor predictive of poor prognosis in patients with breast cancer. Ann Surg Oncol 2008; 15:3244 - 51; http://dx.doi.org/10.1245/s10434-008-0137-2; PMID: 18781363
  • Geng J, Fan J, Wang P, Fang ZJ, Xia GW, Jiang HW, et al. REG1A predicts recurrence in stage Ta/T1 bladder cancer. Eur J Surg Oncol 2009; 35:852 - 7; http://dx.doi.org/10.1016/j.ejso.2008.12.007; PMID: 19167858
  • Sato Y, Motoyama S, Nanjo H, Ito S, Yoshino K, Sasaki T, et al. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy. [Epub Ahead of Print] Ann Surg Oncol 2013; http://dx.doi.org/10.1245/s10434-013-2983-9; PMID: 23645481
  • Greenberg ES, Chong KK, Huynh KT, Tanaka R, Hoon DS. Epigenetic biomarkers in skin cancer. Cancer Lett 2012; http://dx.doi.org/10.1016/j.canlet.2012.01.020; PMID: 22289720
  • Rodenhiser D, Mann M. Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 2006; 174:341 - 8; http://dx.doi.org/10.1503/cmaj.050774; PMID: 16446478
  • Hoon DS, Spugnardi M, Kuo C, Huang SK, Morton DL, Taback B. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene 2004; 23:4014 - 22; http://dx.doi.org/10.1038/sj.onc.1207505; PMID: 15064737
  • Kitago M, Martinez SR, Nakamura T, Sim MS, Hoon DS. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma. Clin Cancer Res 2009; 15:2988 - 94; http://dx.doi.org/10.1158/1078-0432.CCR-08-3172; PMID: 19336521
  • Nguyen T, Kuo C, Nicholl MB, Sim MS, Turner RR, Morton DL, et al. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics 2011; 6:388 - 94; http://dx.doi.org/10.4161/epi.6.3.14056; PMID: 21081840
  • Tanemura A, Terando AM, Sim MS, van Hoesel AQ, de Maat MF, Morton DL, et al. CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 2009; 15:1801 - 7; http://dx.doi.org/10.1158/1078-0432.CCR-08-1361; PMID: 19223509
  • Yoshimura T, Nagahara M, Kuo C, Turner RR, Soon-Shiong P, Hoon DS. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment. Epigenetics 2011; 6:1001 - 11; http://dx.doi.org/10.4161/epi.6.8.16063; PMID: 21725199
  • Kagara N, Huynh KT, Kuo C, Okano H, Sim MS, Elashoff D, et al. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer. Am J Pathol 2012; 181:257 - 67; http://dx.doi.org/10.1016/j.ajpath.2012.03.019; PMID: 22626806
  • Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31:1869 - 83; http://dx.doi.org/10.1038/onc.2011.384; PMID: 21892204
  • Neyns B, Tosoni A, Hwu WJ, Reardon DA. Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects. Cancer 2010; 116:2868 - 77; http://dx.doi.org/10.1002/cncr.25035; PMID: 20564393
  • Miyata H, Doki Y, Shiozaki H, Inoue M, Yano M, Fujiwara Y, et al. CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers. Clin Cancer Res 2000; 6:4859 - 65; PMID: 11156245
  • Takasawa S, Ikeda T, Akiyama T, Nata K, Nakagawa K, Shervani NJ, et al. Cyclin D1 activation through ATF-2 in Reg-induced pancreatic beta-cell regeneration. FEBS Lett 2006; 580:585 - 91; http://dx.doi.org/10.1016/j.febslet.2005.12.070; PMID: 16405968
  • Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009; 55:611 - 22; http://dx.doi.org/10.1373/clinchem.2008.112797; PMID: 19246619
  • Narita N, Tanemura A, Murali R, Scolyer RA, Huang S, Arigami T, et al. Functional RET G691S polymorphism in cutaneous malignant melanoma. Oncogene 2009; 28:3058 - 68; http://dx.doi.org/10.1038/onc.2009.164; PMID: 19561646
  • Triche TJ Jr., Weisenberger DJ, Van Den Berg D, Laird PW, Siegmund KD. Low-level processing of Illumina Infinium DNA Methylation BeadArrays. Nucleic Acids Res 2013; 41:e90; http://dx.doi.org/10.1093/nar/gkt090; PMID: 23476028
  • McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. REporting recommendations for tumour MARKer prognostic studies (REMARK). Eur J Cancer 2005; 41:1690 - 6; http://dx.doi.org/10.1016/j.ejca.2005.03.032; PMID: 16043346

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.